Affordability Check
How to afford Rubraca
Generic name: rucaparib
Pick how you're covered. We'll show you the cheapest legitimate way to get Rubraca — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Rubraca and its cost
What is this medication? Rubraca, which is known by its generic name rucaparib, is a prescription medication classified as a poly ADP-ribose polymerase inhibitor, or PARP inhibitor. It is primarily used for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer whose tumors have responded to previous platinum-based chemotherapy. The medication works by blocking an enzyme that helps repair damaged DNA within cells; by inhibiting this process in cancer cells, Rubraca can cause the cells to die and help slow the progression of the disease.
In addition to its use in gynecological cancers, Rubraca is indicated for the treatment of certain adult patients with a specific type of advanced prostate cancer known as metastatic castration-resistant prostate cancer. Specifically, it is used for patients who have a confirmed deleterious BRCA mutation and who have already undergone treatment with androgen receptor-directed therapy and taxane-based chemotherapy. Because this is a targeted therapy, healthcare providers typically perform genetic testing to confirm the presence of these mutations before starting the treatment.
Rubraca is made by Pharmaand. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Rubraca?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Rubraca?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Pharmaand has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Rubraca?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Prostate Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Rubraca
Full Rubraca drug page
FDA label, prior authorization rules, full indications list
More options for Prostate Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3